Kristine Werner Ozug, MS (@kriswerner1118) 's Twitter Profile
Kristine Werner Ozug, MS

@kriswerner1118

Ideator | Implementor | Teacher | Pioneer | Researcher | Writer | Medical Geek | Yogi | Bird Watcher | Painter? | John's Wife | Dog Lover | Lives with MS

ID: 3113370661

linkhttp://www.realtalkms.com calendar_today28-03-2015 17:08:26

253 Tweet

115 Followers

284 Following

Jon Strum (@realtalkms_jon) 's Twitter Profile Photo

Looking for a clear understanding of exactly how PBMs impact the healthcare ecosystem and control the price of your prescription medications? This video is for you.

Kristine Werner Ozug, MS (@kriswerner1118) 's Twitter Profile Photo

Join me – contact your U.S. Representative and U.S. Senators in Congress today in support of PBM reform. It only takes a minute! nmss.quorum.us/campaign/152939

Kristine Werner Ozug, MS (@kriswerner1118) 's Twitter Profile Photo

On Tues, Jan 20, Congress released details of a bipartisan funding bill, a “minibus” agreed upon by House and Senate appropriators, which includes $15 million for the Multiple Sclerosis Research Program (MSRP) - and more! Send a message to Congress today! nmss.quorum.us/campaign/153657

Jon Strum (@realtalkms_jon) 's Twitter Profile Photo

realtalkms.com/438 Why do MS symptoms and progression vary so widely from person to person? New science suggests the answer may lie in distinct biological subtypes of MS. Discover more on RealTalk MS. 🎧 #MSResearch #RealTalkMS #MultipleSclerosis #MSEducation

Jon Strum (@realtalkms_jon) 's Twitter Profile Photo

realtalkms.com/439🚨Big news in MS research: the first coordinated global strategy to prevent MS has officially been announced. This is a major shift—from managing MS to stopping it before it starts. We’re talking about it on RealTalk MS. #MultipleSclerosis #MSResearch

Jon Strum (@realtalkms_jon) 's Twitter Profile Photo

realtalkms.com/440 🚨 In December, the FDA issued a Complete Response Letter to Sanofi for Tolebrutinib, a first-in-class investigational MS therapy. Not a rejection — but not an approval either. We’re talking about it on RealTalk MS. #MultipleSclerosis #RealTalkMS

Jon Strum (@realtalkms_jon) 's Twitter Profile Photo

realtalkms.com/441 The 2026 ACTRIMS Forum reminded us that progress in MS comes from innovation and mentoring the next generation of MS researchers. Catch up with RealTalk MS before the week starts. Listen wherever you get podcasts. 🎧 #MSResearch #RealTalkMS

Jon Strum (@realtalkms_jon) 's Twitter Profile Photo

realtalkms.com/443 Food choices. MRI findings. Disability progression. The science connecting them is evolving — and we break it down in plain language on RealTalk MS. #MSAwareness #MultipleSclerosis #MSCommunity

Jon Strum (@realtalkms_jon) 's Twitter Profile Photo

realtalkms.com/444 Ozempic. Wegovy. Mounjaro. Zepbound. What if a GLP-1 drug could do more than treat diabetes and support weight loss? What if one could impact progressive MS? We’re breaking down the science on this week’s episode of #RealTalkMS. 🎧 #MultipleSclerosis

Jon Strum (@realtalkms_jon) 's Twitter Profile Photo

realtalkms.com/445 Meet Kim W. and Kim P. They’ve been partners for 16 years—and they both live with MS, but their experiences look very different. Their story highlights just how diverse the MS journey can be. 🎧 On this week’s RealTalk MS. #UnseenMS #MSAwarenessWeek

Jon Strum (@realtalkms_jon) 's Twitter Profile Photo

realtalkms.com/445 Living with MS often means adapting—not just once, but again and again. Rehabilitation, therapy, and support can make a huge difference in daily life. Hear more on this week’s RealTalk MS. #MSAwarenessWeek #MSCommunity #MultipleSclerosis #RealTalkMS

Kristine Werner Ozug, MS (@kriswerner1118) 's Twitter Profile Photo

I’m adding my voice to the 175 MS Activists on Capitol Hill this week to advocate for MS research funding and to support affordable, comprehensive healthcare. Join me! Personalize your message to Congress to maximize its impact: nmss.quorum.us/campaign/158697

Jon Strum (@realtalkms_jon) 's Twitter Profile Photo

realtalkms.com/449 Researchers analyzed 20 global studies to determine whether high-efficacy disease-modifying therapies (Ocrevus, Kesimpta, and Briumvi) were cost-effective. We're sharing their somewhat surprising research results. On RealTalk MS #MultipleSclerosis

realtalkms.com/449
Researchers analyzed 20 global studies to determine whether high-efficacy disease-modifying therapies (Ocrevus, Kesimpta, and Briumvi) were cost-effective. We're sharing their somewhat surprising research results. On RealTalk MS #MultipleSclerosis
Kristine Werner Ozug, MS (@kriswerner1118) 's Twitter Profile Photo

Thank you to the National MS Society for sharing our powerful episode and for giving space to stories like mine. I’m grateful to have had the opportunity to talk about my MS journey on Jon Strum: realtalkms.com/445 facebook.com/reel/263499510…

Jon Strum (@realtalkms_jon) 's Twitter Profile Photo

realtalkms.com/451 What do yaks have to do with MS? 🐃 Scientists are studying animals that survive in low-oxygen environments— because their biology may hold clues to: → Myelin repair → Neuroprotection 🎧 Discover more on RealTalk MS. #MultipleSclerosis #RealTalkMS

Jon Strum (@realtalkms_jon) 's Twitter Profile Photo

realtalkms.com/451 Patients and doctors don’t always agree on what “good” MS care looks like. And that gap? It matters. Find out how it can impact treatment decisions and outcomes on RealTalk MS.🎧 #MSCommunity #PatientExperience #HealthcareQuality #MSAwareness